Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
AC Immune (ACIU) had Weighted-Average Shares Outstanding (Diluted) of 100.89M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$1.17M |
|
$-19.81M |
|
-- |
|
$1.17M |
|
$21.37M |
|
$-20.20M |
|
$0.38M |
|
$-19.81M |
|
$-19.81M |
|
$-19.81M |
|
$-19.81M |
|
$-19.81M |
|
$-19.81M |
|
$-20.20M |
|
$-19.39M |
|
100.89M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
100.89M |
$-0.20 |
|
$-0.20 |
|
| Balance Sheet Financials | |
$142.13M |
|
$2.76M |
|
$72.30M |
|
$214.42M |
|
$122.81M |
|
-- |
|
$13.59M |
|
$136.40M |
|
$78.02M |
|
$15.03M |
|
$78.02M |
|
-- |
|
| Cash Flow Statement Financials | |
$-65.92M |
|
$59.40M |
|
$-0.95M |
|
$45.33M |
|
$34.66M |
|
$-10.66M |
|
$4.36M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.16 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-1721.62% |
|
-1721.62% |
|
-- |
|
-1688.82% |
|
-1688.82% |
|
$-66.89M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
0.59 |
|
151.63 |
|
-25.40% |
|
-131.84% |
|
-9.24% |
|
-25.40% |
|
-- |
|
$-0.66 |
|
$-0.65 |
|